Chromosome constitution of human embryos generated after in vitro maturation including 3-isobutyl-1-methylxanthine in the oocyte collection medium

Human Reproduction

Volumn 30, Issue 3, 2015, Pages 653-663

  Spits, C ^a,b   Guzman, L ^a   Mertzanidou, A ^a,b   Jacobs, K ^a,b   Ortega Hrepich, C ^a,b   Gilchrist, R B ^c   Thompson, J G ^d   De Vos, M ^a,b   Smitz, J ^a   Sermon, K ^a,b  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b CENTRE FOR REPRODUCTIVE MEDICINE   (Belgium)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

chromosomal abnormality; Embryo; In vitro maturation; Single cell aCGH

Indexed keywords

GONADOTROPIN; ISOBUTYLMETHYLXANTHINE; PHOSPHODIESTERASE INHIBITOR; CULTURE MEDIUM;

ADULT; ANEUPLOIDY; ARTICLE; BLASTOMA; CANCER PATIENT; CHROMOSOME ABERRATION; CHROMOSOME STRUCTURE; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; EMBRYO; FEMALE; GERM CELL; HUMAN; HUMAN CELL; IN VITRO OOCYTE MATURATION; IN VITRO STUDY; OOCYTE; OOCYTE MATURATION; PREGNANCY RATE; ADVERSE EFFECTS; CULTURE MEDIUM; EMBRYO CULTURE; INTRACYTOPLASMIC SPERM INJECTION; OOCYTE RETRIEVAL; PHYSIOLOGY; PROCEDURES; STATISTICS AND NUMERICAL DATA;

1-METHYL-3-ISOBUTYLXANTHINE; ADULT; ANEUPLOIDY; BLASTOMERES; CHROMOSOME ABERRATIONS; CULTURE MEDIA; EMBRYO CULTURE TECHNIQUES; FEMALE; HUMANS; IN VITRO OOCYTE MATURATION TECHNIQUES; OOCYTE RETRIEVAL; SPERM INJECTIONS, INTRACYTOPLASMIC;

EID: 84935078452     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deu329     Document Type: Article

References (59)

1. Albuz FK, Sasseville M, Lane M, Armstrong DT, Thompson JG, Gilchrist RB. Simulated physiological oocyte maturation (SPOM): a novel in vitro maturation system that substantially improves embryo yield and pregnancy outcomes. Hum Reprod 2010;25:2999-3011.
2. Ao A, Jin S, Rao D, Son W-Y, Chian R-C, Tan SL. First successful pregnancy outcome after preimplantation genetic diagnosis for aneuploidy screening in embryos generated from natural-cyclein vitro fertilization combined with an in vitro maturation procedure. Fertil Steril 2006;85:1510. e9-1510. e11.
3. Baart EB, Martini E, van den Berg I, Macklon NS, Galjaard R-JH, Fauser BCJM, Van Opstal D. Preimplantation genetic screening revealsahigh incidence of aneuploidy and mosaicisminembryos from young women undergoing IVF. Hum Reprod 2006;21:223-233.
4. Benkhalifa M, Demirol A, Ménézo Y, Balashova E, Abduljalil AK, Abbas S, Giakoumakis I, Gurgan T. Natural cycle IVF and oocyte in-vitro maturation in polycystic ovary syndrome: a collaborative prospective study. Reprod Biomed Online 2009;18:29-36.
5. Bielanska M, Tan SL, Ao A. Chromosomal mosaicism throughout human preimplantation development in vitro: incidence, type, and relevance to embryo outcome. Hum Reprod 2002;17:413-419.
6. Buckett WM, Chian R-C, Holzer H, Dean N, Usher R, Tan SL. Obstetric outcomes and congenital abnormalities after in vitro maturation, in vitro fertilization, and intracytoplasmic sperm injection. Obstet Gynecol 2007;110:885-891.
7. Buckett WM, Chian R-C, Dean NL, Sylvestre C, Holzer HEG, Tan SL. Pregnancy loss in pregnancies conceived after in vitro oocyte maturation, conventional in vitro fertilization, and intracytoplasmic sperm injection. Fertil Steril 2008;90:546-550.
8. Cha KY, Koo JJ, Ko JJ, Choi DH, Han SY, Yoon TK. Pregnancy after in vitro fertilization of human follicular oocytes collected from nonstimulated cycles, their culture in vitro and their transfer in a donor oocyte program. Fertil Steril 1991;55:109-113.
9. Cobo AC, Requena A, Neuspiller F, Aragones M, Mercader A, Navarro J, Simón C, Remohi J, Pellicer A. Maturation in vitro of human oocytes from unstimulated cycles: selection of the optimal day for ovum retrieval based on follicular size. Hum Reprod 1999;14:1864-1868.
10. Dal Canto MB, Mignini Renzini M, Brambillasca F, Cepparo H, Comi R, Villa A, Rangoni G, Mastrolilli M, Crippa M, de Ponti E et al. IVM-the first choice for IVF in Italy. Reprod Biomed Online 2006;13:159-165.
11. Daphnis DD, Fragouli E, Economou K, Jerkovic S, Craft IL, Delhanty JD, Harper JC. Analysis of the evolution of chromosome abnormalities in human embryos from day 3 to 5 using CGH and FISH. Mol Hum Reprod 2008;14:117-125.
12. De Vos M, Ortega-Hrepich C, Albuz FK, Guzman L, Polyzos NP, Smitz J, Devroey P. Clinical outcome of non-hCG-primed oocyte in vitro maturation treatment in patients with polycystic ovaries and polycystic ovary syndrome. Fertil Steril 2011;96:860-864.
13. Fadini R, Dal Canto MB, Mignini Renzini M, Brambillasca F, Comi R, Fumagalli D, Lain M, Merola M, Milani R, De Ponti E. Effect of different gonadotrophin priming on IVM of oocytes from women with normal ovaries: a prospective randomized study. Reprod Biomed Online 2009;19:343-351.
14. Fadini R, Mignini Renzini M, Guarnieri T, Dal Canto M, De Ponti E, Sutcliffe A, Shevlin M, Comi R, Coticchio G. Comparison ofthe obstetric and perinatal outcomesofchildren conceived frominvitroorinvivo matured oocytes inin vitro maturation treatments with births from conventional ICSI cycles. Hum Reprod 2012;27:3601-3608.
15. Fadini R, Mignini Renzini M, Dal Canto M, Epis A, Crippa M, Caliari I, Brigante C, Coticchio G. Oocyte in vitro maturation in normo-ovulatory women. Fertil Steril 2013;99:1162-1169.
16. Fauser BC, Van Heusden AM. Manipulation of human ovarian function: physiological concepts and clinical consequences. Endocr Rev 1997; 18:71-106.
17. Gilchrist RB. Recent insights into oocyte-follicle cell interactions provide opportunities for the development of new approaches to in vitro maturation. Reprod Fertil Dev 2011;23:23-31.
18. Gremeau A-S, Andreadis N, Fatum M, Craig J, Turner K, Mc Veigh E, Child T. In vitro maturationorinvitro fertilization for women with polycystic ovaries? A case-control study of 194 treatment cycles. Fertil Steril 2012; 98:355-360.
19. Gutiérrez-Mateo C, Colls P, Sánchez-Garćia J, Escudero T, Prates R, Ketterson K, Wells D, Munné S. Validation of microarray comparative genomic hybridization for comprehensive chromosome analysis of embryos. Fertil Steril 2011;95:953-958.
20. Guzman L, Ortega-Hrepich C, Polyzos NP, Anckaert E, Verheyen G, Coucke W, Devroey P, Tournaye H, Smitz J, De Vos M. Aprediction model to select PCOS patients suitable for IVM treatment based on anti-Mullerian hormone and antral follicle count. Hum Reprod 2013;28:1261-1266.
21. Jacobs K, Mertzanidou A, Geens M, Nguyen HT, Staessen C, Spits C. Low-grade chromosomal mosaicism in human somatic and embryonic stem cell populations. Nat Commun 2014;5:4227.
22. Jensen JT, Schwinof KM, Zelinski-Wooten MB, Conti M, De Paolo LV, Stouffer RL. Phosphodiesterase 3 inhibitors selectively block the spontaneous resumption of meiosis by macaque oocytes in vitro. Hum Reprod 2002;17:2079-2084.
23. Johnson DS, Gemelos G, Baner J, Ryan A, Cinnioglu C, Banjevic M, Ross R, Alper M, Barrett B, Frederick J et al. Preclinical validation of a microarray method for full molecular karyotyping of blastomeres in a 24-h protocol. Hum Reprod 2010;25:1066-1075.
24. Jurema MW, Nogueira D. In vitro maturation of human oocytes for assisted reproduction. Fertil Steril 2006;86:1277-1291.
25. Luciano AM, Pocar P, Milanesi E, Modina S, Rieger D, Lauria A, Gandolfi F. Effect of different levels of intracellular cAMP on the in vitro maturation of cattle oocytes and their subsequent development following in vitro fertilization. Mol Reprod Dev 1999;54:86-91.
26. ′-monophosphate concentration and oocyte-cumulus cells communications on the acquisition of the developmental competence during in vitro maturation of bovine oocyte. Biol Reprod 2004;70:465-472.
27. Mertzanidou A, Wilton L, Cheng J, Spits C, Vanneste E, Moreau Y, Vermeesch JR, Sermon K. Microarray analysis reveals abnormal chromosomal complements in over 70% of 14 normally developing human embryos. Hum Reprod 2013a;28:256-264.
28. Mertzanidou A, Spits C, Nguyen HT, Vande Velde H, Sermon K. Evolution of aneuploidy up to Day 4 of human preimplantation development. Hum Reprod 2013b;28:1716-1724.
29. Nagaoka SI, Hassold TJ, Hunt P. Human aneuploidy: mechanisms and new insights into an age-old problem. Nat Rev Genet 2012;13:493-504.
30. Nayot D, Chung JT, Son W-Y, Ao A, Hughes M, Dahan MH. Live birth following serial vitrification of embryos and PGD for fragile X syndrome in a patient with the premutation and decreased ovarian reserve. J Assist Reprod Genet 2013;30:1439-1444.
31. Nogueira D, Cortvrindt R, De Matos DG, Vanhoutte L, Smitz J. Effect of phosphodiesterase type 3 inhibitor on developmental competence of immature mouse oocytes in vitro. Biol Reprod 2003;69:2045-2052.
32. Nogueira D, Ron-El R, Friedler S, Schachter M, Raziel A, Cortvrindt R, Smitz J. Meiotic arrestinvitrobyphosphodiesterase 3-inhibitor enhances maturation capacity of human oocytes and allows subsequent embryonic development. Biol Reprod 2006;74:177-184.
33. Papanikolaou EG, D'haeseleer E, Verheyen G, Van de Velde H, Camus M, Van Steirteghem A, Devroey P, Tournaye H. Lie birth rate is significantly higher after blastocyst transfer than after cleavage-stage embryo transfer when at least four embryos are available on day 3 of embryo culture. A randomized prospective study. Hum Reprod 2005;20:3198-3203.
34. Park J-Y, Su Y-Q, Ariga M, Law E, Jin S-L C, Conti M. EGF-like growth factors as mediators of LH action in the ovulatory follicle. Science 2004; 303:682-684.
35. Peluffo MC, Ting AY, Zamah AM, Conti M, Stouffer RL, Zelinski MB, Hennebold JD. Amphiregulin promotes the maturation of oocytes isolated from the small antral follicles of the rhesus macaque. Hum Reprod 2012;27:2430-2437.
36. Pincus G, Enzmann EV. The comparative behavior of mammalian eggs in vivo and in vitro?: i. The activationof ovarian eggs. J Exp Med 1935;62:665-675.
37. Richani D, Wang X, Zeng HT, Smitz J, Thompson JG, Gilchrist RB. Pre-maturation with cAMP modulators in conjunction with EGF-like peptides during in vitro maturation enhances mouse oocyte developmental competence. Mol Reprod Dev 2014a;81:422-435.
38. Richani D, Sutton-Mc Dowall ML, Frank LA, Gilchrist RB, Thompson JG. Effect of epidermal growth factor-like peptides on the metabolism of in vitro-matured mouse oocytes and cumulus cells. Biol Reprod 2014b;90:49.
39. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks relatedtopolycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41-47.
40. Russell DL, Robker RL. Molecular mechanisms of ovulation: co-ordination through the cumulus complex. Hum Reprod Update 2007;13:289-312.
41. Scriven PN. The scope, limitations and interpretation of copy number detection in the early embryo using the array CGH technique. Hum Reprod 2013;28:2-5.
42. Shu Y, Zeng H, Ren Z, Zhuang G, Liang X, Shen H, Yao S, Ke P, Wang N. Effects of cilostamide and forskolin on the meiotic resumption and embryonic development of immature human oocytes. Hum Reprod 2008;23:504-513.
43. Smitz JEJ, Thompson JG, Gilchrist RB. The promise of in vitro maturation in assisted reproduction and fertility preservation. Semin Reprod Med 2011; 29:24-37.
44. Son W-Y, Tan SL. Laboratory and embryological aspects of hCG-primed in vitro maturation cycles for patients with polycystic ovaries. Hum Reprod Update 2010;16:675-689.
45. Svendsen PF, Madsbad S, Nilas L. The insulin-resistant phenotype of polycystic ovary syndrome. Fertil Steril 2010;94:1052-1058.
46. Swanton A, Storey L, Mc Veigh E, Child T. IVF out come in women with PCOS, PCO and normal ovarian morphology. Eur J Obstet Gynecol Reprod Biol 2010;149:68-71.
47. ′-monophosophate levels. Biol Reprod 2004;70:548-556.
48. Treff NR, Levy B, Su J, Northrop LE, Tao X, Scott RT. SNP microarray-based 24 chromosome aneuploidy screening is significantly more consistent than FISH. Mol Hum Reprod 2010;16:583-589.
49. Trounson A, Wood C, Kausche A. Invitro maturation and the fertilization and developmental competence of oocytes recovered from untreated polycystic ovarian patients. Fertil Steril 1994;62:353-362.
50. Tsafriri A, Chun SY, Zhang R, Hsueh AJ, Conti M. Oocytematuration involves compartmentalization and opposing changes of cAMP levels in follicular somatic and germ cells: studies using selective phosphodiesterase inhibitors. Dev Biol 1996;178:393-402.
51. Van Echten-Arends J, Mastenbroek S, Sikkema-Raddatz B, Korevaar JC, Heineman MJ, van der Veen F, Repping S. Chromosomal mosaicism in human preimplantation embryos: a systematic review. Hum Reprod Update 2011;17:620-627.
52. Vanhoutte L, Nogueira D, Dumortier F, De Sutter P. Assessment of a new in vitro maturation system for mouse and human cumulus-enclosed oocytes: three-dimensional prematuration culture in the presence of a phosphodiesterase 3-inhibitor. Hum Reprod 2009;24:1946-1959.
53. Vanneste E, Voet T, Le Caignec C, Ampe M, Konings P, Melotte C, Debrock S, Amyere M, Vikkula M, Schuit F et al. Chromosome instability is common in human cleavage-stage embryos. Nat Med 2009;15:577-583.
54. Vanneste E, Melotte C, Voet T, Robberecht C, Debrock S, Pexsters A, Staessen C, Tomassetti C, Legius E, D'Hooghe T et al. PGD for a complex chromosomal rearrangement by array comparative genomic hybridization. Hum Reprod 2011;26:941-949.
55. Voullaire L, Slater H, Williamson R, Wilton L. Chromosome analysis of blastomeres from human embryos by using comparative genomic hybridization. Hum Genet 2000;106:210-217.
56. Wells D, Delhanty JD. Comprehensive chromosomal analysis of human preimplantation embryos using whole genome amplification and single cell comparative genomic hybridization. Mol Hum Reprod 2000;6:1055-1062.
57. Zamah AM, Hsieh M, Chen J, Vigne JL, Rosen MP, Cedars MI, Conti M. Human oocyte maturation is dependent on LH-stimulated accumulation of the epidermal growth factor-like growth factor, amphiregulin. Hum Reprod 2010;25:2569-2578.
58. Zeng H-T, Ren Z, Guzman L, Wang X, Sutton-Mc Dowall ML, Ritter LJ, De Vos M, Smitz J, Thompson JG, Gilchrist RB. Heparin and cAMP modulators interact during pre-in vitro maturation to affect mouse and human oocyte meiosis and developmental competence. Hum Reprod 2013;28:1536-1545.
59. Zhang XY, Ata B, Son W-Y, Buckett WM, Tan S-L, Ao A. Chromosome abnormality rates in human embryos obtained from in-vitro maturation and IVF treatment cycles. Reprod Biomed Online 2010;21:552-559.